000 | 02007 a2200505 4500 | ||
---|---|---|---|
005 | 20250514192831.0 | ||
264 | 0 | _c20040802 | |
008 | 200408s 0 0 eng d | ||
022 | _a0001-6349 | ||
024 | 7 |
_a10.1111/j.0001-6349.2004.00433.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ade Mello, Nilson Roberto | |
245 | 0 | 0 |
_aDouble-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea. _h[electronic resource] |
260 |
_bActa obstetricia et gynecologica Scandinavica _cJul 2004 |
||
300 |
_a667-73 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Tolerance |
650 | 0 | 4 |
_aDysmenorrhea _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGastrointestinal Diseases _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMefenamic Acid _xadverse effects |
650 | 0 | 4 | _aMeloxicam |
650 | 0 | 4 |
_aThiazines _xadverse effects |
650 | 0 | 4 |
_aThiazoles _xadverse effects |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aBaracat, Edmund Chada | |
700 | 1 | _aTomaz, Geraldez | |
700 | 1 | _aBedone, Aloísio José | |
700 | 1 | _aCamargos, Aroldo | |
700 | 1 | _aBarbosa, Ione Cristina | |
700 | 1 | _ade Souza, Rosival Nassar | |
700 | 1 | _aRumi, Demetrio Ortega | |
700 | 1 | _aMartinez Alcala, Felix Octavio | |
700 | 1 | _aVelasco, Jorge Antonio Aldrete | |
700 | 1 | _aCortes, Roberto Jose Risco | |
773 | 0 |
_tActa obstetricia et gynecologica Scandinavica _gvol. 83 _gno. 7 _gp. 667-73 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.0001-6349.2004.00433.x _zAvailable from publisher's website |
999 |
_c14929893 _d14929893 |